Polycystic ovary syndrome and its developmental origins.
The prenatal testosterone (T)-treated adult female rhesus monkey is one animal model of polycystic ovary syndrome (PCOS) in women, with early prenatal T excess programming a permanent PCOS-like phenotype characterized by luteinizing hormone (LH) hypersecretion from reduced hypothalamic sensitivity to steroid negative feedback and relative insulin excess from increased abdominal adiposity. These combined reproductive and metabolic abnormalities are associated with ovarian hyperandrogenism and follicular arrest in adulthood, as well as premature follicle differentiation and impaired embryo development during gonadotropin therapy for in vitro fertilization (IVF). A second animal model for PCOS, the prenatal T-treated sheep also is characterized by LH hypersecretion from reduced hypothalamic sensitivity to steroid negative feedback, persistent follicles and insulin resistance, but also is associated with intrauterine growth retardation and compensatory growth after birth. The ability of prenatal T excess in both species to alter the developmental trajectory of multiple organ systems in utero provides evidence that the hormonal environment of intrauterine life programs target tissue differentiation, raising the possibility that T excess in human fetal development promotes PCOS in adulthood. Such a hypothesis must include data from clinical studies of PCOS women to clarify the homology between these PCOS-like animal models and PCOS per se in reproductive and metabolic function. Future studies should develop new clinical strategies that improve pregnancy outcome and minimize pregnancy loss in women with disorders of insulin action, including PCOS, obesity and diabetes mellitus as well as minimize transgenerational susceptibility to adult PCOS and its metabolic derangements in male close relatives.
Dumesic
Daniel A
DA
Wisconsin National Primate Research Center, University of Wisconsin, Madison, WI 53715, USA. danieldumesic@aol.com
Abbott
David H
DH
Padmanabhan
Vasantha
V
D000818:Animals; D005260:Female; D006801:Humans; D007328:Insulin / Q000378:metabolism; D007986:Luteinizing Hormone / Q000378:metabolism*; D008954:Models, Biological; D009765:Obesity / Q000150:complications; D011085:Polycystic Ovary Syndrome / Q000209:etiology / Q000378:metabolism* / Q000473:pathology
D007328:Insulin; D007986:Luteinizing Hormone